KK
ANAB icon

KLP Kapitalforvaltning’s AnaptysBio ANAB Stock Holding History

KLP Kapitalforvaltning’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$203K Hold
3,000
– – ﹤0.01% 1893
2026
Q1 		$166K Hold
3,000
– – ﹤0.01% 1886
2025
Q4 		$145K Hold
3,000
– – ﹤0.01% 1953
2025
Q3 		$91.9K Hold
3,000
– – ﹤0.01% 2078
2025
Q2 		$66.6K Hold
3,000
– – ﹤0.01% 2123
2025
Q1 		$55.8K Hold
3,000
– – ﹤0.01% 2182
2024
Q4 		$39.7K Buy
+3,000
New +$72.7K ﹤0.01% 2261

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

KLP Kapitalforvaltning's ANAB Position: Q2 2026 in Review

KLP Kapitalforvaltning held its AnaptysBio (ANAB) position steady in Q2 2026 at 3,000 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #1893.

KLP Kapitalforvaltning first reported a position in ANAB in Q4 2024 and has held it in 7 quarters since. 214 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • KLP Kapitalforvaltning held 3,000 shares of AnaptysBio worth $203K as of Q2 2026.
  • KLP Kapitalforvaltning left its AnaptysBio share count unchanged in Q2 2026.
  • AnaptysBio made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1893 holding.
  • KLP Kapitalforvaltning first reported a position in AnaptysBio in Q4 2024 and has held it in 7 quarters since.
  • 214 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.